Bone Biologics Corporatio...

NASDAQ: BBLG · Real-Time Price · USD
2.25
-0.10 (-4.26%)
At close: Aug 15, 2025, 12:15 PM

Bone Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-4.11M -8.95M -1.48M -1.61M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
188.82K 152.6K 266.63K 207.03K
Other Working Capital
-240.03K -122.95K -956.92K 45K
Other Non-Cash Items
-51.08K -892.69K -2.18M 495.55K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-150.25K 132.92K -168.37K -320.49K
Operating Cash Flow
-4.12M -9.56M -3.57M -1.23M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a 1.05M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-3.21M n/a n/a n/a
Other Financial Acitivies
5.02M n/a n/a n/a
Financial Cash Flow
4.42M 5.04M 4.43M 7.9M
Net Cash Flow
298.56K -4.51M 862.95K 6.68M
Free Cash Flow
-4.12M -9.56M -3.57M -1.23M